Mechanisms of cannabidiol neuroprotection in hypoxic–ischemic newborn pigs: Role of 5HT1A and CB2 receptors
- 31 August 2013
- journal article
- Published by Elsevier BV in Neuropharmacology
- Vol. 71, 282-291
- https://doi.org/10.1016/j.neuropharm.2013.03.027
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Cannabidiol, a non‐psychotropic component of cannabis, attenuates vomiting and nausea‐like behaviour via indirect agonism of 5‐HT1A somatodendritic autoreceptors in the dorsal raphe nucleusBritish Journal of Pharmacology, 2011
- Dopamine D1-histamine H3 Receptor Heteromers Provide a Selective Link to MAPK Signaling in GABAergic Neurons of the Direct Striatal PathwayOnline Journal of Public Health Informatics, 2011
- International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1and CB2Pharmacological Reviews, 2010
- Synergistic neuroprotective therapies with hypothermiaSeminars in Fetal and Neonatal Medicine, 2010
- Therapeutic Potential of Non-Psychotropic Cannabidiol in Ischemic StrokePharmaceuticals, 2010
- Cannabidiol ameliorates cognitive and motor impairments in bile‐duct ligated mice via 5‐HT1A receptor activationBritish Journal of Pharmacology, 2010
- A transient antioxidant stress response accompanies the onset of disuse atrophy in human skeletal muscleJournal of Applied Physiology, 2009
- Building a new conceptual framework for receptor heteromersNature Chemical Biology, 2009
- The nonpsychoactive component of marijuana cannabidiol modulates chemotaxis and IL-10 and IL-12 production of murine macrophages both in vivo and in vitroJournal of Neuroimmunology, 2005
- Cytokines and acute neurodegenerationNature Reviews Neuroscience, 2001